Approved indications:

• Indicated for the treatment of high blood pressure (hypertension) in adults, either alone or in combination with other antihypertensive drugs.
• Can be used as initial therapy in adults who are likely to need more than one blood pressure medicine, but initial use is generally not recommended in people 75 years or older or those with liver impairment.

Off-label uses and evidence:

• The fixed-dose combination is not widely used for off-label indications; instead, clinicians typically use the individual components (for example, amlodipine alone for angina) when treating other conditions.
• There is limited direct evidence supporting off-label uses specific to this combination beyond blood pressure control.

Efficacy expectations:

• Blood pressure usually begins to improve within the first week, with most of the effect seen within about 2 weeks after a dose change.
• Clinical trials show greater reductions in blood pressure with the combination than with either amlodipine or olmesartan alone at comparable doses.
• When blood pressure is controlled to similar levels, long-term outcomes (like stroke or heart attack risk) are expected to be comparable to other modern combinations of calcium channel blockers and angiotensin receptor blockers.

Typical dosing and how to take it:

• Adults are usually started at 5 mg amlodipine / 20 mg olmesartan once daily by mouth; the dose may be increased after 1–2 weeks up to a maximum of 10 mg / 40 mg once daily.
• Tablets are taken once a day at about the same time, with or without food, swallowed whole with water.
• The medicine can be used alone or together with other blood pressure medicines; pediatric dosing is not established.

Special dosing instructions:

• Initial combination therapy is generally avoided in adults aged 75 years or older or in those with liver impairment; such patients are often first stabilized on the individual components.
• People with kidney problems, low blood volume, or heart failure may need closer monitoring and slower dose adjustments.

Missed dose and overdose:

• If you miss a dose, take it as soon as you remember unless it is almost time for your next dose; if it is close to the next dose, skip the missed one and resume your regular schedule—do not double up.
• In suspected overdose (symptoms may include severe dizziness, fainting, or very slow or fast heartbeat), seek emergency medical care or contact Poison Control at 1-800-222-1222 right away.

Common side effects:

• Swelling of the ankles, feet, or hands (peripheral edema), headache, dizziness, flushing, and fatigue are among the most common and are often mild to moderate.
• Low blood pressure (hypotension) or lightheadedness may occur, especially when starting treatment, increasing the dose, or if you are dehydrated.
• Some people may notice palpitations, rash, or increased urination.

Serious or rare adverse effects (seek immediate medical attention):

• Allergic reactions, including swelling of the face, lips, tongue, or throat, trouble breathing, or severe rash.
• Severe chest pain or signs of heart attack, particularly soon after starting or raising the amlodipine dose.
• Severe dizziness or fainting from very low blood pressure.
• Signs of kidney problems (such as greatly reduced urination, sudden weight gain, or swelling) or high potassium (muscle weakness, abnormal heart rhythm).
• Persistent severe diarrhea and weight loss can rarely signal an olmesartan-associated intestinal problem.

Warnings and precautions:

• Pregnancy: drugs that act on the renin–angiotensin system can harm or kill an unborn baby; this medicine must be stopped if pregnancy occurs and should not be used during pregnancy.
• Breastfeeding: not recommended because of limited safety data and possible risk to the infant.
• Age limits: safety and effectiveness have not been established in children; use is for adults only.
• Kidney or liver disease, heart failure, significant valve disease, or very low blood volume (from high-dose diuretics, vomiting, or diarrhea) may require extra caution, lower doses, or alternative therapy.

Safety compared with other blood pressure drugs and reporting side effects:

• Overall safety is similar to other angiotensin receptor blocker/calcium channel blocker combinations, with less cough than ACE inhibitors but a risk of swelling, low blood pressure, and kidney effects.
• Side effects can be reported to the FDA’s MedWatch program (online or at 1-800-FDA-1088) or to the manufacturer, and updated safety information is posted on these sites as it becomes available.

Key drug and food interactions:

• Other blood pressure medicines, diuretics, or nitrates can add to blood pressure–lowering effects and increase the risk of dizziness or fainting.
• Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or naproxen may reduce the blood pressure effect and increase the risk of kidney problems, especially in older adults or those with kidney disease.
• Potassium-sparing diuretics, potassium supplements, and salt substitutes containing potassium can raise potassium levels and should be used only under medical supervision.
• Simvastatin doses greater than 20 mg daily should generally be avoided with amlodipine because they can increase statin levels and muscle-related side effects.
• Strong CYP3A4 inhibitors (for example, certain antifungals or macrolide antibiotics) can raise amlodipine levels, while strong inducers (such as rifampin) may reduce its effect.
• Alcohol can intensify blood pressure lowering and dizziness.
• Using aliskiren with this medicine is contraindicated in patients with diabetes and generally avoided in those with kidney dysfunction.

Conditions and co-medications requiring caution:

• Significant kidney or liver impairment, severe heart failure, severe aortic stenosis, or recent heart attack may require alternative therapy or very careful dosing.
• People with a history of angioedema, chronic diarrhea, or unexplained weight loss on olmesartan should be monitored closely or switched to another agent.

Monitoring needs:

• Regular blood pressure checks at home and in the clinic to guide dose adjustments.
• Periodic blood tests to monitor kidney function and electrolytes, especially potassium, particularly after dose changes or when used with other medicines that affect the kidneys or potassium.
• Additional monitoring may be needed if used with other cardiovascular drugs or in patients with complex heart disease.

Q: How long does it take for amlodipine and olmesartan medoxomil to start lowering my blood pressure?
A: Many people see some improvement within the first week, with most of the blood pressure–lowering effect reached within about 2 weeks after a dose change.

Q: Do I need to take this medicine with food or at a specific time of day?
A: You can take it with or without food, but it is best to take it at the same time each day (morning or evening) to help you remember and keep blood levels steady.

Q: Can I stop taking this medication once my blood pressure is controlled?
A: No, blood pressure often rises again if the medicine is stopped; any change in dose or discontinuation should be guided by your healthcare provider.

Q: Is it safe to drink alcohol while taking this drug?
A: Alcohol can enhance the blood pressure–lowering effects and increase dizziness or fainting, so discuss your usual alcohol intake with your clinician and use caution.

Q: What should I do if I become pregnant or am planning to become pregnant?
A: This medicine can seriously harm an unborn baby and should not be used during pregnancy; if you are pregnant or planning pregnancy, contact your healthcare provider promptly to switch to a safer alternative.

Storage:

• Store tablets at room temperature, generally 68–77°F (20–25°C), away from excess heat, moisture, and direct light.
• Keep the medication in its original, tightly closed container and out of reach of children and pets.

Disposal:

• Do not flush tablets down the toilet unless specifically instructed by local guidance.
• Use a community drug take‑back program if available, or mix unused tablets with an undesirable substance (such as used coffee grounds or cat litter), seal in a bag or container, and place in the household trash.
• Before discarding, scratch out or remove personal information on prescription labels.